chitosan has been researched along with Nasal Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, SY | 1 |
Bedi, R; Bird, GH; Boyapalle, S; Crannell, WC; Devareddy, A; Mohapatra, S; Mohapatra, SS; Nguyen, H; Opoku-Nsiah, K; Perry, AF; Sampayo, V; Walensky, LD; Wong, T | 1 |
Coaker, H | 1 |
Weber, RK | 1 |
1 review(s) available for chitosan and Nasal Diseases
Article | Year |
---|---|
[Nasal packing after FESS--time is over?].
Topics: Chitosan; Cicatrix; Endoscopy; Foreign-Body Reaction; Formaldehyde; Gelatin Sponge, Absorbable; Hemostatic Techniques; Hemostatics; Humans; Nasal Mucosa; Nasal Obstruction; Nose Diseases; Polyurethanes; Polyvinyl Alcohol; Postoperative Care; Postoperative Complications; Risk Assessment; Tampons, Surgical; Wound Healing | 2009 |
3 other study(ies) available for chitosan and Nasal Diseases
Article | Year |
---|---|
Allergic rhinitis.
Topics: Animals; Chitosan; Desensitization, Immunologic; Dextrans; Hemangiopericytoma; Humans; Nose Diseases | 2013 |
Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection.
Topics: Animals; Cell Line; Chitosan; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Nanoparticles; Nose Diseases; Peptides; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Viral Fusion Proteins | 2014 |
Double-stapled respiratory syncytial virus may prevent nasopulmonary infection.
Topics: Chitosan; Humans; Nanoparticles; Nose Diseases; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Viral Fusion Proteins | 2014 |